titanium silicide: Clinical Trials

12 trials of titanium silicide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 12 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 7, Unknown 2, Active not recruiting 1, Recruiting 1, Suspended 1
Phase 25Unknown 2, Completed 1, Recruiting 1, Suspended 1

Follow titanium silicide: new trials by email Literature Review of titanium silicide trials Research Report on titanium silicide

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
hypofractionated radiotherapy, PD-1 inhibitor, TS-1 - Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy
Phase 1 / Phase 2RecruitingWest China Hospital842025-11-182026-01-06
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
TBI-1401(HF10), Gemcitabine, Nab-paclitaxel - Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV
Phase 1Active not recruitingTakara Bio Inc.362017-09-252024-12-09
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
OIS (Oxaliplatin, Irinotecan, S-1) - Gastrointestinal Neoplasms
Phase 1CompletedHallym University Medical Center222012-06-012016-02-19
SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
s1, Oxaliplatin - Gastric Cancer
Phase 1 / Phase 2UnknownChinese Academy of Medical Sciences712011-06-012016-06-14
Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Gemcitabine, S-1 - Biliary Tract Cancer
Phase 1CompletedKansai Hepatobiliary Oncology Group62010-12-012014-10-23
A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer
TS-1 with Cisplatin - Gastric Cancer
Phase 1CompletedYonsei University62009-12-012013-06-04
Sorafenib Plus S-1 in Advanced Solid Tumors
Sorafenib, S-1 - Advanced Solid Tumors
Phase 1CompletedNational Health Research Institutes, Taiwan302009-11-012015-10-19
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma
sorafenib, TS-1 - Hepatocellular Carcinoma
Phase 1CompletedSamsung Medical Center202009-09-012012-02-02
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
Cediranib, Cisplatin, S-1 - Gastric Cancer
Phase 1CompletedAstraZeneca142009-08-012011-06-14
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Irinotecan, Cisplatin, TS-1 (S-1) - Advanced Non-Small Cell Lung Cancer
Phase 1 / Phase 2UnknownNational Cancer Center, Korea742008-10-012010-10-25
A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer
TS-1, oxaliplatin - Colorectal Neoplasms
Phase 1 / Phase 2CompletedSamsung Medical Center772006-08-012009-07-02
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Taxotere, TS-1 - Gastric Cancer
Phase 1 / Phase 2SuspendedHokkaido Gastrointestinal Cancer Study Group502005-04-012010-05-26

Conditions studied

Stomach Neoplasms (4)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Samsung Medical Center (2)  ·  AstraZeneca (1)  ·  Chinese Academy of Medical Sciences (1)  ·  Hallym University Medical Center (1)  ·  Hokkaido Gastrointestinal Cancer Study Group (1)  ·  Kansai Hepatobiliary Oncology Group (1)  ·  National Cancer Center, Korea (1)  ·  National Health Research Institutes, Taiwan (1)  ·  Takara Bio Inc. (1)  ·  West China Hospital (1)  ·  Yonsei University (1)

Countries

South Korea (5)  ·  Japan (4)  ·  China (2)  ·  Taiwan (1)

Top investigators

Dae Young Zang, MD, PhD (1)  ·  Heung Tae Kim, M.D. (1)  ·  Hiroaki Nagano, MD, PhD (1)  ·  Li-Tzong Chen, M.D., Ph.D. (1)  ·  Lin Yang, MD (1)  ·  Masahiro Asaka, MD, PhD (1)  ·  Narikazu Boku, MD (1)  ·  Young Suk Park, M.D., Ph.D. (1)

Results publications

PMID 15160338, PMID 15169795, PMID 15289858, PMID 29743043